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Abstract
Background: Self-harm in adolescents is of growing concern internationally but limited evidence exists on the
prevalence of self-harm in those living with HIV, who may be at higher risk of poor mental health outcomes. Therefore
our aim was to determine the prevalence and predictors of self-harm among young people with perinatally-acquired
HIV (PHIV) and HIV negative (with sibling or mother living with HIV) young people living in England.
Methods: 303 PHIV and 100 HIV negative young people (aged 12–23 years) participating in the Adolescents
and Adults Living with Perinatal HIV cohort study completed an anonymous self-harm questionnaire, as well
as a number of standardised mental-health assessments. Logistic regression investigated predictors of self-
harm.
Results: The median age was 16.7 years in both groups, and 40.9% of the PHIV and 31.0% of the HIV negative groups
were male. In total 13.9% (56/403) reported having ever self-harmed, with no difference by HIV status (p = 0.089).
Multivariable predictors of self-harm were female sex (adjusted odds ratio (AOR) 5.3, (95% confidence interval 1.9, 14.1),
p = 0.001), lower self-esteem (AOR 0.9 (0.8, 0.9) per 1 point increase, p < 0.001) and having ever used alcohol (AOR 3.8
(1.8, 7.8), p < 0.001). Self-esteem z-scores for both PHIV and HIV negative participants were 1.9 standard deviations
below the mean for population norms.
Conclusions: Self-harm is common among PHIV and HIV negative adolescents in England. Reassuringly however, they
do not appear to be at an increased risk compared to the general adolescent population (15–19% lifetime prevalence).
The low level of self-esteem (compared to available normative data) in both groups is worrying and warrants further
attention.
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Introduction
Advancements in the medical care of children with peri-
natally acquired human immunodeficiency virus (HIV)
have substantially improved their prognosis. As a result,
large numbers of children living with HIV are now matur-
ing into adolescence and early adulthood [1]. Adolescence
is a time when many mental health problems, as well as
behaviours that may increase the risk of mental health
problems, emerge [2]. Children growing up with a life
threatening and often highly stigmatised infection such as
HIV may be at a particularly high risk for mental health
problems, including self-harm and suicide.
Self-harm refers to an intentional act of self-injury or
self-poisoning carried out by an individual, irrespective
of motivation [3]. It includes behaviours such as cutting,
overdose or self-poisoning, self-battering and burning
[4]. In large population-based studies, of those adoles-
cents reporting self-harm, cutting was identified as the
most prevalent method and repeat episodes of self-harm
were common [5–7]. Furthermore, very few of those
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who self-harm present to hospital for medical attention
[8]. Whilst it is clear that not all self-harm is suicidal in
nature, a follow-up study of over 40,000 patients present-
ing to hospitals in England found the age-adjusted risk of
completed suicide in the first year following self-harm to
be 49 times higher than in the general population [9].
Self-harm was identified as an emerging problem in the
United Kingdom (UK) in the 1960s [10]. There has how-
ever, been renewed prioritisation on understanding sui-
cidal phenomena such as self-harm as suicide among
adolescents has become increasingly prominent, now the
second most common cause of mortality in 15–29 year
olds [11] and the most common cause of death in females
aged 15–19 globally [4].
Numerous risk factors and correlates of self-harm have
been identified. The most vulnerable age for initiating
self-harm behaviours seems to be between 11 and 14 years
[6, 12, 13], with females more at risk than males [4].
Whilst ethnicity has not consistently been identified as a
risk factor for self-harm [14], there is some evidence that
young black females are a particularly high risk group in
the UK [15]. Furthermore, underlying psychological vari-
ables such as impulsivity, low self-esteem, depression, and
anxiety have all been associated with self-harm [16].
Finally, a number of studies have found an association
between suicidal phenomena in adolescents and alcohol
and drug use [17].
In the last 5 years, three large studies have estimated
prevalence of self-harm in adolescents in England using
anonymous self-completed questionnaires. In a study of
almost 4000 12–16 year olds recruited from schools,
Stallard et al reported a 15% prevalence of self-harm in
the preceding year [6]. In a further study of 2000 adoles-
cents aged 13–18 years recruited by a market research
agency from across England a lifetime prevalence of
15.5% was reported [12]. Finally, the Avon Longitudinal
Study of Parents and Children (ALSPAC) birth cohort
reported an 18.8% lifetime prevalence of self-harm
among almost 5000 16–17 year old participants [5]. A
recent UK study utilising national databases to investigate
trends over time reported an increase in the incidence of
self-harm from 45.9 per 10,000 in 2011 to 77.0 per 10,000
in 2014 among girls aged 13–16 [18].
Similar rates of self-harm have been reported across
Europe. In the Child and Adolescent Self-harm in Europe
(CASE) study, among more than 30,000 15–16 year olds
from 7 different European countries, a lifetime history of
self-harm was reported by 13.5 and 4.3% of females and
males respectively [7].
Very few studies have reported prevalence of self-harm
and suicide among young people with perinatally-acquired
HIV (PHIV). One study of psychiatric hospitalisation
among PHIV children < 15 years of age in the USA found
that 18.7% of participants who were hospitalised during
the study period were admitted because of suicidal
attempts or ideation [19]. Further evidence from Kenya
identified suicidality but no previous suicide attempts in
18% of the 162 6–18 year old participants with PHIV [20].
In a case-control study of 10–17 year old children from
Rwanda, over 20% of the 218 HIV positive and 228 HIV
negative children with a caregiver living with HIV had
engaged in suicidal behaviour in the preceding 6months
[21]. In this study the odds of suicidal behaviour almost
doubled among those living with HIV compared to the
237 HIV negative children with no HIV in their family
(OR 1.85, 95% confidence interval (CI): 1.12, 3.05, 21).
Finally, in the first study to report on mortality outcomes
post-transition to adult care for young people with
PHIV in the UK, suicide was the cause of two out of 11
deaths [22]. On the basis of this limited evidence it
seems likely that suicidal ideation and self-harm are
common amongst adolescents with PHIV, and since
self-harm has been repeatedly identified as the stron-
gest risk factor for subsequent suicide [23] there is an
urgency to investigate the prevalence of, and the associ-
ated risk factors for self-harm in this population.
A number of studies investigating the effect of HIV
infection on adolescent mental health lack an appropriate
comparator group. However, mental health outcomes are
affected by a complex interaction of genetic, biomedical,
psychosocial and environmental influences [24]. For
example, PHIV children have at least one biological parent
living with HIV, and are therefore more likely to experi-
ence parental illness or even death, which may result in
multiple caretaking transitions [25]. In the UK, a high pro-
portion of PHIV children were born abroad (mainly in
sub-Saharan Africa), and may therefore be exposed to the
stressors of immigration and cultural adjustment [1, 26].
Therefore a comparator group which can approximate the
life experiences of growing up with HIV in the household
would help to isolate the effect of HIV infection itself on
mental health outcomes of young people with PHIV.
The objective of this study was to determine the
prevalence of self-harm among young people with PHIV
and an appropriate comparison group of HIV negative
young people living in England.
Methods
The Adolescents and Adults Living with Perinatal HIV
(AALPHI) cohort study is evaluating the impact of HIV
infection and ART exposure on young people with PHIV
and HIV negative young people in England. Participants
were enrolled from HIV clinics and community services
in England between 2013 and 2015. Detailed methods
have been described previously [27]. All participants
with PHIV had known their HIV status for at least 6
months and were aged 12–21 years. HIV negative young
people were aged 13–23 years, had a negative point-of-
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care HIV test result at interview, and had either a sibling
or parent with HIV. All participants had lived in the UK
for 6 months or longer, could speak and understand
English, and were able to give informed consent to par-
ticipate in the study.
Participants underwent a two-hour face-to-face inter-
view with a trained research nurse. Computer-Assisted
Self-Interview (CASI) was used for sensitive questions. A
series of questions assessed self-harm (the first question
being “Have you ever hurt yourself on purpose in any way
(e.g. by taking an overdose of pills, or by cutting your-
self)?”), including the frequency and type of self-harm
behaviours, as well as the presence or absence of suicidal
intent during self-harming. Questions were adapted from
the Avon Longitudinal Study of Parents and Children
(ALSPAC) [5, 28, 29].
Levels of anxiety and depression symptoms were
measured using the Hospital Anxiety and Depression Scale
(HADS) [30], and standard definitions were used for
categories. Self-esteem was measured using the Rosenberg
self-esteem scale (scores range from 0 to 30: higher scores
indicating better self-esteem) [31]. Health-related quality of
life (HRQL) was measured using the Pediatric Quality of
Life Inventory (PedsQL™ 4.0) (Teenage report for 13–18
and Young Adult report for 18–25 years), and a composite
total score ranged between 0 and 100 (with higher scores
representing better HRQL). Body image satisfaction was
measured using four questions from the Minneapolis-Man-
chester Quality of Life Instrument (MMQL) [32] body
image domain. Scores range from 0 to 100 (with higher
scores indicating greater satisfaction with physical appear-
ance.) For each test z-scores were calculated from norma-
tive data [33–36], with scores above zero indicating better
clinical status. Major life events were assessed using a 21
item checklist, used in the ALSPAC study, which included
events related to family, friends, and self. Higher total
scores indicate less distress from significant life events in
the preceding year. Normative data were not available for
this measure and so z-scores were not calculated.
Data were analysed using STATA version 14 (Stata
Corp, College Station, Texas, USA). Chi squared and
Fisher’s exact tests were used to compare proportions;
Wilcoxon rank sum and t-tests compared median and
means respectively. Results are presented for non-missing
values; missing values were less than 10% of study partici-
pants unless specified. The effect of potential predictors of
self-harm were explored using logistic regression model-
ling. Factors considered a priori to be associated with self-
harm for all participants were age, sex and HIV status.
Other variables considered were: sociodemographic
(ethnicity, birth outside the United Kingdom/Ireland);
social/ family factors (currently living with parents/carers,
living in original nuclear family (both biological parents),
parent or caregiver employed, death of one or both
parents, number of main carers (adults taking responsibil-
ity for the participant during childhood), previous contact
with social services or educational support services);
mental health factors (HRQL, Rosenberg self-esteem, body
image satisfaction score, HADS depression and anxiety,
and effects of major life events scores); and lifestyle/behav-
ioural factors (ever alcohol, ever cannabis, ever recre-
ational drug use other than cannabis). Variables with p <
0.15 in univariable analysis were considered in multivari-
able analysis using backward selection, and a two-tailed
p < 0.05 was considered statistically significant.
An additional model for only the PHIV young people
considered the additional effect of CD4 count and viral load
suppression < 50 c/ml within 6months of interview, self
report of antiretroviral therapy adherence (not missing any
doses in the last 3 days or more than two consecutive days
in the last month), age at HIV disclosure, and current feel-
ings about HIV diagnosis (5-item visual analogue scale to
score how upset, sad and alone participants felt in relation
to their HIV diagnosis, as well as how much they think
about their diagnosis and worry about their future health),
on levels of self-harm. For this analysis HIV-related vari-
ables were obtained through linkage to the Collaborative
HIV Paediatric Study (CHIPS) database [26].
Full ethical approval for the AALPHI study was obtained
from Leicester Research Ethics Committee.
Results
Sample characteristics
A total of 303 PHIV and 100 HIV negative participants
had self-harm data. Of the HIV negative participants,
47.0% had PHIV siblings (39 of whom were in AALPHI),
49.0% had a mother living with HIV, and 4.0% had a
close friend with PHIV. Sociodemographics of the two
groups were similar (Table 1). A slightly higher propor-
tion of PHIV compared to HIV negative participants
were male (40.9% vs. 31.0%, p = 0.077) but their age
distribution was similar, with a median age overall of
16.7 years. A higher proportion of PHIV participants
were black African (85.8% vs. 73.0%, p = 0.003) and were
born outside the UK (58.4% vs. 47.0%, p = 0.046). The
majority of participants were living at home with parents
or caregivers (90.3% overall), but far fewer were living in
their original nuclear family (21.1% overall).
Mental health parameters were generally comparable
between the two groups, with the exception of HRQL
scores, where PHIV participants’ z-scores were lower
than HIV negative participants (− 0.8 vs. -0.4, p = 0.007).
Z-scores for anxiety, depression and body image satisfac-
tion for both groups were close to zero, indicating
similarity to normative data, however participants from
both groups had significantly lower self-esteem z-scores
compared with normative data (− 1.9 (standard deviation
(SD) 1.5) overall).
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Prevalence of self-harm
A lifetime history of self-harm was reported in 13.9% (56/
403) of participants overall, and 12.2% of PHIV participants
and 19.0% of HIV negative participants (p = 0.089). Of
those who had self-harmed, almost half (25/53, 47.2%) had
done so in the 12months preceding the interview. Of these
participants 36.0% (9/25) reported only one episode of self-
harm in the last year, and the remainder reported 2–5
Table 1 Participant characteristics by HIV status
Total (n = 403) PHIV (n = 303) HIV- (n = 100) P value
n (%) or mean {SD} or median [IQR]
Sociodemographics
Male sex 155 (38.5) 124 (40.9) 31 (31.0) 0.077
Age group
≤ 15 years 157 (39.0) 115 (38.0) 42 (42.0) 0.541
16–18 years 160 (39.7) 125 (41.2) 35 (35.0)
≥ 19 years 86 (21.3) 63 (20.8) 23 (23.0)
Age, median [IQR] 16.7 [15.0, 18.6] 16.7 [15.1,18.5] 16.7 [14.5,18.7] 0.770
Black ethnicity 333 (82.6) 260 (85.8) 73 (73.0) 0.003
Born outside UK/Ireland 224 (55.6) 177 (58.4) 47 (47.0) 0.046
Social/ family factors
Live with parents/carers 363 (90.3) 274 (90.7) 89 (89.0) 0.613
Live in original nuclear family 85 (21.1) 69 (22.9) 16 (16.0) 0.146
Parent/carer employed 274 (69.9) 217 (73.6) 57 (58.8) 0.006
Biological parent vital status:
Both parents alive 249 (65.7) 178 (62.7) 71 (74.7) 0.093
One parent deceased 112 (29.6) 92 (32.4) 20 (21.1)
Both parents deceased 18 (4.8) 14 (4.9) 4 (4.2)
Number of carersa 1 [1.0,2.0] 1 [1.0,2.0] 1 [1.0,2.0] 0.297
Ever contact with social services 112 (28.4) 83 (27.8) 29 (30.2) 0.643
Ever contact with educational support services 103 (25.8) 84 (28.0) 19 (19.0) 0.075
Mental health factors
PedsQL HRQL score 76.7 {14.0} 75.6 {13.9} 79.8 {13.7} 0.009
z score −0.7 {1.2} −0.8 {1.2} −0.4 {1.2} 0.007
Rosenberg self-esteem score 20.6 {5.3} 20.6 {5.2} 20.7 {5.5} 0.977
z score −1.9 {1.5} −1.9 {1.5} −1.9 {1.6} 0.953
MMQL body image satisfaction score 64.3 {23.2} 64.4 {22.6} 63.9 {25.2} 0.850
z score −0.2 {0.9} −0.2 {0.8} −0.2 {0.9} 0.850
HADS Depression score 3.8 {3.1} 3.9 {3.1} 3.5 {2.9} 0.245
z score −0.1 {0.8} −0.1 {0.8} 0.0 {0.8} 0.154
HADS Anxiety score 6.4 {4.0} 6.5 {3.9} 6 {4.1} 0.268
z score −0.1 {0.9} 0.0 {0.8} −0.2 {0.9} 0.133
Major life events −0.1 {2.7} 0.0 {2.6} −0.4 {3.0} 0.270
Lifestyle/ behavioural factors
Ever used alcohol 163 (42.5) 120 (41.5) 43 (45.3) 0.522
Ever used cannabis 68 (18.2) 42 (14.8) 26 (28.6) 0.003
Ever used other recreational drugs 15 (4.0) 10 (3.5) 5 (5.5) 0.373
PHIV perinatally-acquired HIV, HIV- HIV negative
anumber of adults taking responsibility for the participant during childhood
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episodes (11/25, 44.0%) or > 5 episodes (5/25, 20.0%). Forty-
four per cent (11/25) of those who self-harmed in the last
12months were aged ≤15 years, 36% (9/25) 16–18 years,
and 20% (5/25) ≥19 years, and 92% (23/25) were female.
The most common methods of self-harm overall were
cutting, either alone or in combination with other methods
(27/56, 48.2% and 8/56, 14.3% respectively), and swallowing
pills or other poisonous substances (15/56, 26.8% alone and
5/56, 8.9% in combination). After the last episode of self-
harm, the majority (43/56, 76.8%) did not require any med-
ical attention but 14.3% (8/56) sought medical assistance at
hospital emergency departments (Table 2).
Prevalence of suicidal intent in those who had self-
harmed
Just under half (26/56, 46.4%) of those who had self-
harmed reported suicidal intent at any previous episode of
self-harm, and nearly all of these participants reporting
feeling their life was not worth living and they wished they
were dead and away from it all (Table 2). There were no
differences in repeated self-harm, method of self-harming,
number who went to hospital (Table 2), sociodemographic
or social/family factors (data not shown) between those
who had self-harmed with and without suicidal intent.
However, a higher proportion of those who reported sui-
cidal intent had prior contact with social services (15/26,
57.7%) compared to those without suicidal intent (6/29,
20.7% respectively, p = 0.05).
Self-harm and mental health scores
Figure 1 presents mean z-scores for each mental health
test for participants with no history of self-harm, self-harm
without suicidal intent, and self-harm with suicidal intent.
Mean z-scores for all three groups were below reference
means for body image satisfaction score, self-esteem and
quality of life. Anxiety and depression scores for the three
groups were closer to zero. With the exception of depres-
sion score, there was a consistent trend for a progressive
reduction in z-score across the groups, with those report-
ing no self-harm having the highest z-scores, and those
reporting self-harm with suicidal intent the lowest z-
scores. Mean (SD) raw scores for the major life events
variable were consistent with this trend (no self-harm 0.1
(2.7), self-harm with no suicidal intent − 0.3 (2.9), self-
harm with suicidal intent − 2.1 (2.5).
Predictors of self-harm
Table 3 presents univariable and multivariable predictors
of self-harm. Before and after adjustment for other vari-
ables, HIV status was not associated with self-harm
(adjusted p = 0.212). Prevalence of self-harm was higher
in females (20.6%) compared to males (3.2%) and after
adjustment, the odds of self-harm were 5 times greater
in females than males (adjusted odds ratio (AOR) 5.3,
95% CI 1.9, 14.1, p = 0.001). Each 1-point increase in the
Rosenberg self-esteem score was associated with a 10%
reduction in adjusted odds of self-harm (95% CI: 0.8, 0.9,
p < 0.001). The prevalence and odds of self-harm were
also higher in those who had ever used alcohol (AOR 3.8,
95% CI: 1.8, 7.8, p < 0.001). No other factors were associ-
ated with self-harm in multivariable analysis. Two sensi-
tivity analyses, one including only female participants, and
another including Rosenberg self-esteem z-scores, found
no difference in predictors of self-harm (data not shown).
In the separate model for PHIV young people, multivari-
able predictors of self-harm were the same as the overall
model, with similar effect size (data not shown).
Discussion
The overall results from this study are commensurate with
results from a number of large population studies on self-
harm in adolescents both in the UK and internationally.
This study found an overall prevalence of self-harm of
13.9%, with girls carrying a disproportionate burden. One
in five girls in the AALPHI study reported at least one
episode of self-harm, and nearly all (23/25) of those who
Table 2 Prevalence of self-harm thoughts and actions by presence of suicidal intent
Variable Total (n = 56) Self-harm without
suicidal intent (n = 30)
Self harm with




Ever felt life was not worth living? 47 (83.9) 21 (70.0) 26 (100.0) 0.002
Ever wished you were dead and away from it all?a 41 (87.2) 16 (76.2) 25 (96.2) 0.041
Actions
Repeated self-harmb 16 (64.0) 4 (44.4) 12 (75.0) 0.127
Swallowed pills/ poisonous substance at last self-harm 20 (35.7) 9 (30.0) 11 (42.3) 0.338
Cutting at last self-harm 35 (62.5) 20 (66.7) 15 (57.7) 0.489
Presented to hospital after last self-harm 8 (14.3) 2 (6.7) 6 (23.1) 0.166
aunknown for 9 self-harm without suicidal intent; b > 1 episode, of those who had self-harmed in the preceding 12 months (N = 25 overall, N = 9 and 16 without
or with suicidal intent respectively)
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self-harmed in the preceding 12months were female. Fur-
thermore, this study found similar patterns of self-harm
behaviour to those described in the existing literature,
with a predominance of self-cutting (62.5%), high levels of
repetition (64.0%), and low levels of help seeking behav-
iour at hospitals or emergency department after self-harm
(14.3%). This reaffirms the evidence that self-harm is a
common problem in adolescent community populations
in the UK and is mostly ‘hidden’ from health professionals,
although whether young people with PHIV in our study
had discussed self-harm with staff at their HIV clinic is
unknown.
Importantly, our study did not identify significant dif-
ferences in prevalence of self-harm in the AALPHI co-
hort between those participants living with perinatal
HIV and those who were HIV negative, suggesting that
the impact of HIV infection itself on mental health out-
comes may be less important than the psychosocial mi-
lieu in which these children are raised. The only other
study to date to specifically address suicidal ideation and
behaviour in young people living with HIV also found
no difference in prevalence of suicidal behaviour be-
tween HIV positive and HIV negative affected (seronega-
tive with an HIV positive care-giver) adolescents living
in Rwanda (21.5 and 21.1% respectively) [21]. It did
however find significantly higher levels of suicidal behav-
iour among adolescents living with HIV and children af-
fected by HIV in comparison to HIV negative children
with no HIV in their family (OR 1.9, 95% CI 1.1, 3.1,
and OR 1.9, 95% CI 1.2, 3.1 respectively). In contrast,
our study’s prevalence of self-harm was similar to that
reported in the general UK adolescent population in two
large community based studies [5, 12].
Our study found a strong association between self-esteem
and self-harm. Each one point increase in Rosenberg score
was associated with a 10% reduction in odds of self-harm
(95% CI: 0.8, 0.9, p < 0.001). Similarly the CASE study found
a significant difference in self-esteem scores between those
with no history of self-harm and those with single and
multiple episodes of self-harm, in the general adolescent
population across Europe [16]. Furthermore, a recent study
of nearly 9000 13–19 year olds from Norway found higher
self-esteem was strongly associated with reduced risk of self-
harm hospitalisation [37]. Importantly, self-esteem z-scores
for both groups in AALPHI were almost 2 standard devia-
tions below the mean for general adolescent populations,
possibly highlighting a particular mental health vulnerability
in this population.
Our study did not find an association between self-
harm and depression. This is in contrast to much of the
existing literature. The Rwandan study reported an AOR
of 1.8 (95% CI 1.1, 3.0, p = 0.003) for suicidal behaviour
in adolescents with self-reported scores above the diag-
nostic cut-off for depression compared to those below
the cut-off score [21]. The ALSPAC study found a
greater than 5 times higher odds of self-harm among
participants who scored above diagnostic cut-off for
depressive symptoms than those who scored below [5].
Similarly the CASE study described a dose-response
relationship whereby higher scores of depression were
associated with worsening history of self-harm – from
no self-harm, to self-harm thoughts only, to a single and
Fig. 1 Mental health test z-scores and self-harm with and without suicidal intent
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then multiple episodes of self-harm [7]. The lack of asso-
ciation between depression and self-harm in our study
was thus unexpected. It should not simply be dismissed
as measurement artefact, as although some have criti-
cised the HADS tool [38], the CASE study did find an
association between depression and self-harm using the
HADS [16].
Another possibility is that our study did not detect an
effect of depression due to its relationship with self-esteem,
which itself was a strong predictor of self-harm. Low self-
esteem has been found to both increase an individual’s vul-
nerability to depression, and to be a symptom of depression
[17], and we recently found that lower self-esteem predicted
higher depression scores in the AALPHI cohort [39].
Table 3 Prevalence and predictors of self-harm
Variable Prevalence Univariable Multivariable
n/total (%) OR (95%CI) P value OR (95%CI) P value
A priori factors
HIV status Positive (PHIV) 37/303 (12.2) 1 1
Negative (HIV-) 19/100 (19.0) 1.7 (0.9, 3.1) 0.091 1.6 (0.8, 3.1) 0.212
Sex Male 5/155 (3.2) 1 1
Female 51/248 (20.6) 7.8 (3.0, 19.9) < 0.001 5.3 (1.9, 14.1) 0.001
Age ≤15 years 15/157 (9.6)
16–18 years 27/160 (16.9)
≥19 years 14/86 (16.3)
Per 1 year inc. 1.1 (1.0, 1.2) 0.214 1.0 (0.9, 1.2) 0.924
Other factors
Social services support No 34/283 (12.0) 1
Yes 21/112 (18.8) 1.7 (0.9, 3.1) 0.084
PedsQL (HRQL score) ≥median 14/210 (6.7)
<median 42/191 (22.0)
Per 25 point inc. 0.3 (0.2, 0.5) < 0.001
Rosenberg self-esteem ≥median 14/240 (5.8)
<median 42/162 (25.9)
Per 1 point inc. 0.9 (0.8, 0.9) < 0.001 0.9 (0.8, 0.9) < 0.001
MMQL Body image ≥median 19/232 (8.2)
<median 36/152 (23.7)
Per 25 point inc. 0.5 (0.3, 0.6) < 0.001
HADS Anxiety score Normal (< 8) 22/234 (9.4)
Mild (8–10) 19/80 (23.8)
Moderate (11–14) 9/50 (18.0)
Severe (≥15) 3/12 (25.0)
Per 1 point inc. 1.1 (1.1, 1.2) 0.001
Major life events ≥median 27/250 (10.8)
<median 29/153 (19.0)
Per 1 point inc. 0.9 (0.8, 0.9) 0.002
Ever used alcohol No 17/221 (7.7) 1
Yes 37/163 (22.7) 3.5 (1.9, 6.5) < 0.001 3.8 (1.8, 7.8) < 0.001
Ever cannabis No 35/306 (11.4) 1
Yes 17/68 (25.0) 2.6 (1.3, 5) 0.004
Ever other drugs No 48/359 (13.4) 1
Yes 4/15 (26.7) 2.4 (0.7, 7.7) 0.156
Only factors associated with self-harm at univariable (p < 0.15) or multivariable (p < 0.05) level are shown
PHIV perinatally-acquired HIV, HIV- HIV negative
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Previous research has shown that low self-esteem and
depressive symptoms often co-occur among the general
population of adolescents [40, 41], although some studies
suggest that the direction of the association between self-es-
teem and depressive symptoms is predominantly from self-
esteem to depressive symptoms [42, 43]. Therefore it
might be the case that some of the adolescents in our
study with low self-esteem are yet to develop depressive
symptoms.
A number of studies that found strong association be-
tween self-harm and depression, including ALSPAC and
the Rwandan study, did not measure self-esteem [5, 21].
However, the CASE study, which examined both self-es-
teem and depression, found an independent association
with self-harm for both [16]. In our study depression was
not significantly related to self-harm in the univariable
model, or in a sensitivity analysis replacing self-esteem
with depression in the multivariable model. A possible
reason for this is that the prevalence of depression overall
was relatively low in our study (84% had a normal HADS
depression score) compared to other studies, and there-
fore an association with self-harm may be harder to
detect. The CASE study which also measured depression
using HADS reported an overall mean (SD) depression
score of 4.4 (3.3, 16) compared to 3.8 (3.1) in our study.
Furthermore whilst different measures of depression were
used in other studies, the prevalence of depression overall
was 26% in the Rwandan study [21], and 45% the in self-
harm group in ALSPAC [5] compared to 23% in AALPHI.
A further possible explanation for the lack of association
between depression and self-harm in our study is that
through the clinical management of HIV and the required
contact with health professionals there may be some mitiga-
tion of mental health vulnerabilities [44]. To date, research
into factors that protect against self-harm is extremely
limited [45], so it is uncertain whether contact with health
professionals does indeed have any affect. However, if this
were the case one would expect higher prevalence of self-
harm or depression in the HIV negative comparison group.
The AALPHI comparator group did in fact have higher
prevalence of self-harm (19.0% vs. 12.2%) however the differ-
ence was not statistically significant (p = 0.089), and there
was no difference in the level of depression between the two
groups in a previous analysis [39].
Finally, our study also found a step-wise deterioration
in all mental health parameters (with the exception of
depression) as we compared the non-self-harm group to
the self-harm without suicidal intent, and the self-harm
with suicidal intent group. Whilst there is controversy
over the clinical usefulness of differentiating self-harm
with suicidal intent [46], this finding is interesting. It
suggests that rather than representing separate entities
such as non-suicidal self-injury and attempted suicide,
that self-harm with and without suicidal intent exist on
a spectrum and may be affected by similar underlying
mental-health parameters.
This study is important as it is the first in the UK to
address the issue of self-harm among young people living
with HIV. The inclusion of an appropriate comparator
group enables the distinction between effects of HIV
infection itself from the surrounding psychosocial envir-
onmental influences. Using definitions of self-harm
consistent with both the ALSPAC and CASE studies
allowed for comparison with these larger general popula-
tion samples. Even though the epidemiology of HIV varies
markedly around the world, and many environmental
factors impact on mental health, this study showed that
young people growing up with HIV in England are at
similar risk of self-harm to young people growing up with
HIV in other countries and to the adolescent population
generally.
The study also has a number of limitations. Firstly, the
reliance on self-report assessment tests introduces the
possibility that participants may give false or inaccurate
responses, or choose not to respond at all. However, we
aimed to minimise this through ensuring anonymity of
questionnaires as well as the use of CASI for sensitive
questions, and the number of missing responses was very
low. Secondly as AALPHI is a larger study addressing
multiple domains, we were constrained by interview
length, and thus used a sub-set of the self-harm questions
from the ALSPAC study. As a result we could not investi-
gate the reasons for self-harm, nor were we able to identify
those who had self-harm thoughts but no actions. Thirdly,
there were a number of challenges to selecting mental
health measurement tools that could be compared to
existing literature. Not only is there great variability with
regards to measures of mental health parameters used in
existing literature, but not all tools have been validated for
adolescent populations or have appropriate normative
data available. Lastly, although all PHIV young people
were invited to join AALPHI, some who self-harm may
not have consented to take part. However we have previ-
ously reported that those who participated were broadly
representative of young people in the national UK and
Ireland paediatric cohort [26].
Despite being seemingly at high risk for self-harm, the
comparable prevalence of self-harm in PHIV young
people to HIV negative adolescents suggest that there
could be protective factors moderating risk. Identification
of these factors could assist with planning community
suicide and self-harm prevention programmes. There is a
poor evidence base for the effectiveness of interventions
to improve self-esteem in HIV positive adolescents. One
randomised trial in rural Zimbabwe found that engage-
ment with community adolescent treatment supporters
improved linkage to services, retention in care, ART ad-
herence and psychosocial wellbeing [47]. Parental support
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within the family may also be a contributing factor in
developing self-esteem in adolescents in the general popu-
lation [48], and may be pertinent for young people
affected by HIV in our study, some of whose parents had
died. Evidence from other disease areas suggests that psy-
chosocial interventions such as cognitive behavioural ther-
apy and family therapy improve psychological outcomes
[49]. In terms of day to day care of PHIV in the UK, the
Children’s HIV Association (CHIVA) has Standards of
Care which every child living with HIV should expect to
receive, and these highlight the importance of psychology
support as an integrated service [50]. Additionally CHIVA
has a Family Conference each year, for parents, carers and
family members of children and young people growing up
with HIV, with a focus on achieving health and wellbeing,
in addition to its annual residential support camp for chil-
dren aged 11–16 years [51, 52].
As the prevention of mother-to-child transmission
programmes improve and expand worldwide, our find-
ings reiterate the importance of increasing awareness
and addressing the mental health vulnerabilities of the
growing population of HIV negative young people who
have been exposed to HIV, who are not routinely in
medical care. A greater understanding of the factors that
both promote and prevent self-harm in this population
could assist with the elucidation of the underlying
aetiology of this worrying behaviour in the general ado-
lescent population. Specifically, the identification of poor
self-esteem among these adolescents, compared to the
general adolescent population, warrants further investi-
gation. In conclusion, this study of PHIV adolescents
and a comparable group of HIV negative young people
in the UK found levels of self-harm similar to the
general adolescent population, and particularly high
among female participants. Self-harm was also found to
be significantly associated with worse self-esteem and
having ever drunk alcohol.
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